Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathway.
The α1A-AR is thought to couple predominantly to the Gαq/PLC pathway and lead to phosphoinositide hydrolysis and calcium mobilization, although certain agonists acting at this receptor have been reported to trigger activation of arachidonic acid formation and MAPK pathways. For several G protein-cou...
Main Authors: | Alicja J Copik, Aleksander Baldys, Khanh Nguyen, Sunil Sahdeo, Hoangdung Ho, Alan Kosaka, Paul J Dietrich, Bill Fitch, John R Raymond, Anthony P D W Ford, Donald Button, Marcos E Milla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4301629?pdf=render |
Similar Items
-
Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR.
by: Qian Yin, et al.
Published: (2016-01-01) -
In vivo pretreatment of Eudrilus eugeniae powder attenuates β-adrenoceptor toxicity mediated by isoproterenol in rat model
by: Jaganathan Anitha, et al.
Published: (2016-08-01) -
Challenges in β-adrenoceptor agonist drug development
by: Jonathan R. S. Arch
Published: (2011-04-01) -
On the Site and Mechanism of Action of β-Adrenoceptor Agonists in the Bladder
by: Karl Erik Andersson
Published: (2017-03-01) -
Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists
by: Khadija Ayed, et al.
Published: (2020-10-01)